Does Edesa Biotech, Inc. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores Edesa Biotech, Inc. (EDSA) 29.4 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 32, returns on capital 0, balance-sheet safety 55, capital discipline 44.

How has EDSA's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 29.4 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

Edesa Biotech, Inc.

EDSA · Healthcare · $46.4M mkt cap · FY2025 filings · No moat ·

Doesn't clear the bar

No moat

The four filters

Pricing power32

Median gross margin 35.6% over 3y, variable.

Returns on capital0

Median ROIC -410.1%, above the 9% hurdle in 0% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline44

Owner earnings trend unclear, share count n/a.

Margin of safety

Above valueOn sale

No price data

Owner earnings (normalized): —
Est. intrinsic value / share: —
Recent price: $6.50
Discount to value: No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for EDSA yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale29.4 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — EDSA has read No moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#352 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#350CVSI CV Sciences, Inc.29.6 out of 100, No moatNo moat
#351LAKE Lakeland Industries, Inc.29.4 out of 100, No moatNo moat
#353ICCC ImmuCell Corporation29.3 out of 100, No moatNo moat
#354OPK OPKO Health, Inc.29.3 out of 100, No moatNo moat

Compare EDSA with its nearest peers →All Healthcare companies on the Index →

Common questions about EDSA

Does Edesa Biotech, Inc. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores Edesa Biotech, Inc. (EDSA) 29.4 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 32, returns on capital 0, balance-sheet safety 55, capital discipline 44.
How has EDSA's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 29.4 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows EDSA’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/EDSA"
  width="340" height="150" style="border:0"
  title="EDSA Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell EDSA. See the disclaimer.